MedPath

A study on assessment of mast cells in oral epithelial dysplasia with Toluidine Blue and Hematoxylin and Eosin stains â?? A pilot study

Not Applicable
Registration Number
CTRI/2019/04/018691
Lead Sponsor
Dr Neha Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Histopathological sections will be obtained from the archival tissue as well as the cases reported during the study in our institution which are histopathological diagnosed as oral epithelial dysplasia.

Subjects without systemic disorders were included for prospective study.

Exclusion Criteria

Histopathological sections other than oral epithelial dysplasia will be excluded in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the role of mast in oral epithelial dysplasiaTimepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
To see the number of mast cells will vary in different grades of oral epithelial dysplasia & their correlation between themTimepoint: 7 days
© Copyright 2025. All Rights Reserved by MedPath